Vimarsana
Biggest News Aggregation in the World

Lead Study Author News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lead Study Author. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lead Study Author Today - Breaking & Trending Today

Genes known to increase the risk of Alzheimer's may actually be an inherited form of the disorder, researchers say | National - Vimarsana News

Genes known to increase the risk of Alzheimer's may actually be an inherited form of the disorder, researchers say | National

Alzheimer’s disease may be inherited more often than previously known, according to a new study that paints a clearer picture of a gene long known to be linked to the

Source: kitv.com
Scientists spot 'glory effect' on a world beyond our solar system for the first time | National - Vimarsana News

Scientists spot 'glory effect' on a world beyond our solar system for the first time | National

Astronomers have spotted what they believe to be a rainbow-like phenomenon occurring on a planet outside our solar system for the first time, and it could reveal new insights about

Source: kitv.com
Bioengineered drug candidate can counter S. aureus infection in early tests - Vimarsana News

Bioengineered drug candidate can counter S. aureus infection in early tests

Researchers at NYU Grossman School of Medicine and Janssen Biotech, Inc. have shown in early tests that a bioengineered drug candidate can counter infection with Staphylococcus aureus – a bacterial species widely resistant to antibiotics and a major cause of death in hospitalized patients.

Black and Hispanic stroke survivors in the U.S. less likely to be treated for certain complications - Vimarsana News

Black and Hispanic stroke survivors in the U.S. less likely to be treated for certain complications

Analysis of 20 years of electronic health records across the U.S. finds Black and Hispanic stroke survivors were less likely than white stroke survivors to receive treatment for common complications during the first year after their stroke, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2023.

Novel gene editing therapy reduces circulating TTR protein levels in patients with ATTR amyloid cardiomyopathy - Vimarsana News

Novel gene editing therapy reduces circulating TTR protein levels in patients with ATTR amyloid cardiomyopathy

A single IV infusion of NTLA-2001, a novel CRISPR/Cas9-based gene editing therapy, significantly reduced circulating transthyretin (TTR) protein levels in patients with ATTR amyloid cardiomyopathy, a progressive and fatal cause of heart failure, according to late-breaking research presented today at the American Heart Association’s Scientific Sessions 2022.